Effect of atorvastatin on inflammatory markers in hemodialysis patients

The Egyptian Journal of Internal Medicine

Table 3 Comparison between the drug and control groups as regards the change in the biochemical data at baseline and after 6 months

	Drug group, mean ± SD	Paired test, P value	Control group, mean ± SD	Paired test, P value	t test, P value
AST	2.636 ± 7.717	0.058	1.650 ± 6.507	0.271	0.635
ALT	1.667 ± 6.406	0.145	− 0.100 ± 8.169	0.957	0.385
CK-T	− 2.061 ± 28.402	0.680	− 10.550 ± 42.960	0.286	0.390
T. cholesterol	54.485 ± 46.438	< 0.001*	− 11.150 ± 40.547	0.234	< 0.001*
HDL	− 3.879 ± 9.215	0.021*	− 0.100 ± 6.617	0.947	0.116
LDL	38.424 ± 41.218	< 0.001*	− 16.800 ± 36.071	0.051*	< 0.001*
Triglycerides	82.061 ± 53.615	< 0.001*	15.850 ± 46.164	0.141	< 0.001*
IL-6, pg/ml	− 0.084 ± 4.641	0.918	− 0.285 ± 4.503	0.780	0.878
hs-CRP, mg/l	4.140 ± 4.530	< 0.001*	− 0.138 ± 4.782	0.899	0.002*

Data are mean ± SD for all variables
hs-CRP highly sensitive C-reactive protein, IL-6 interleukin-6, LDL low-density lipoprotein, HDL high-density lipoprotein, ALT alanine transaminase, AST aspartate transaminase, CK-T total creatine kinase
*Paired sample t test